TLANDO (U.S. Trademark Serial Number 88487154) is a United States trademark of ANTARES PHARMA, INC.. The goods and services include: The mark consists of two vertical nestled arcs slightly offset which precede the word “TLANDO”. Pharmaceutical preparations for the treatment of testosterone deficiency Color is not claimed as a feature of the mark.. The correspondent is Gene K. Park of Morgan, Lewis & Bockius LLP.

This trademark was filed on June 24, 2019 as United States Trademark Application Serial Number 88487154. This trademark application is still pending and does not yet have a registration number.

Trademark PTO Status History

July 04, 2022 – ALLOWED PRINCIPAL REGISTER – SOU ACCEPTED

June 29, 2022 – STATEMENT OF USE PROCESSING COMPLETE

June 16, 2022 – USE AMENDMENT FILED

June 16, 2022 – TEAS STATEMENT OF USE RECEIVED

June 15, 2022 – APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

June 15, 2022 – TEAS CHANGE OF CORRESPONDENCE RECEIVED

June 15, 2022 – ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

June 15, 2022 – TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

View full trademark status information at USPTO

Ownership History

ANTARES PHARMA, INC.

Lipocine Inc.

Lipocine Inc.

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.